Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma

Daisuke Matsui, Ali H. Zaidi, Samantha A. Martin, Ashten N. Omstead, Juliann E. Kosovec, Luai Huleihel, Lindsey T. Saldin, Christina DiCarlo, Jan F. Silverman, Toshitaka Hoppo, Gene G. Finley, Stephen F. Badylak, Ronan Joseph Kelly, Blair A. Jobe

Research output: Contribution to journalArticle

Abstract

Esophageal adenocarcinoma (EAC) is an aggressive cancer necessitating the development of improved risk stratification tools for personalized care. Previously, microRNAs have been shown to correlate with the progression and prognosis of various cancer types; however, the value in EAC remains largely unexplored. We performed global microRNA profiling on 32 formalin-fixed, paraffin-embedded EAC specimens to identify microRNAs associated with progression. Literature search and pathway analysis further refined output to five significantly deregulated candidate biomarkers. Four of the five microRNAs (miR-652-5p, miR-7-2-3p, miR-3925-3p, and miR-219-3p) were validated by qRT-PCR. Survival outcomes were evaluated in testing set of 26 stage II/III EAC patients to determine the prognostic relevance of the selected microRNAs. In the testing set, miR-652-5p and miR-7-2-3p expressions were significantly associated with progression-free survival (p-value = .00771 and p-value = .00293). The highest area under receiver operating characteristic (ROC) curve was 0.8212 for the combination of miR-652-5p and miR-7-2-3p. Collectively, our findings demonstrated that the miR-652-5p/miR-7-2-3p signature may serve as a promising prognostic marker in patients with locally advanced EAC.

Original languageEnglish (US)
Pages (from-to)81281-81291
Number of pages11
JournalOncotarget
Volume7
Issue number49
DOIs
StatePublished - 2016

Fingerprint

MicroRNAs
Adenocarcinoma
Recurrence
Survival
Neoplasms
ROC Curve
Paraffin
Formaldehyde
Disease-Free Survival
Biomarkers
Polymerase Chain Reaction

Keywords

  • Esophageal adenocarcinoma
  • miR-652-5p
  • miR-7-2-3p
  • miRNA
  • Prognostic marker

ASJC Scopus subject areas

  • Oncology

Cite this

Matsui, D., Zaidi, A. H., Martin, S. A., Omstead, A. N., Kosovec, J. E., Huleihel, L., ... Jobe, B. A. (2016). Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma. Oncotarget, 7(49), 81281-81291. https://doi.org/10.18632/oncotarget.12832

Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma. / Matsui, Daisuke; Zaidi, Ali H.; Martin, Samantha A.; Omstead, Ashten N.; Kosovec, Juliann E.; Huleihel, Luai; Saldin, Lindsey T.; DiCarlo, Christina; Silverman, Jan F.; Hoppo, Toshitaka; Finley, Gene G.; Badylak, Stephen F.; Kelly, Ronan Joseph; Jobe, Blair A.

In: Oncotarget, Vol. 7, No. 49, 2016, p. 81281-81291.

Research output: Contribution to journalArticle

Matsui, D, Zaidi, AH, Martin, SA, Omstead, AN, Kosovec, JE, Huleihel, L, Saldin, LT, DiCarlo, C, Silverman, JF, Hoppo, T, Finley, GG, Badylak, SF, Kelly, RJ & Jobe, BA 2016, 'Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma', Oncotarget, vol. 7, no. 49, pp. 81281-81291. https://doi.org/10.18632/oncotarget.12832
Matsui, Daisuke ; Zaidi, Ali H. ; Martin, Samantha A. ; Omstead, Ashten N. ; Kosovec, Juliann E. ; Huleihel, Luai ; Saldin, Lindsey T. ; DiCarlo, Christina ; Silverman, Jan F. ; Hoppo, Toshitaka ; Finley, Gene G. ; Badylak, Stephen F. ; Kelly, Ronan Joseph ; Jobe, Blair A. / Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma. In: Oncotarget. 2016 ; Vol. 7, No. 49. pp. 81281-81291.
@article{8f1a8c9b8ec44f04abc51603a5800aef,
title = "Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma",
abstract = "Esophageal adenocarcinoma (EAC) is an aggressive cancer necessitating the development of improved risk stratification tools for personalized care. Previously, microRNAs have been shown to correlate with the progression and prognosis of various cancer types; however, the value in EAC remains largely unexplored. We performed global microRNA profiling on 32 formalin-fixed, paraffin-embedded EAC specimens to identify microRNAs associated with progression. Literature search and pathway analysis further refined output to five significantly deregulated candidate biomarkers. Four of the five microRNAs (miR-652-5p, miR-7-2-3p, miR-3925-3p, and miR-219-3p) were validated by qRT-PCR. Survival outcomes were evaluated in testing set of 26 stage II/III EAC patients to determine the prognostic relevance of the selected microRNAs. In the testing set, miR-652-5p and miR-7-2-3p expressions were significantly associated with progression-free survival (p-value = .00771 and p-value = .00293). The highest area under receiver operating characteristic (ROC) curve was 0.8212 for the combination of miR-652-5p and miR-7-2-3p. Collectively, our findings demonstrated that the miR-652-5p/miR-7-2-3p signature may serve as a promising prognostic marker in patients with locally advanced EAC.",
keywords = "Esophageal adenocarcinoma, miR-652-5p, miR-7-2-3p, miRNA, Prognostic marker",
author = "Daisuke Matsui and Zaidi, {Ali H.} and Martin, {Samantha A.} and Omstead, {Ashten N.} and Kosovec, {Juliann E.} and Luai Huleihel and Saldin, {Lindsey T.} and Christina DiCarlo and Silverman, {Jan F.} and Toshitaka Hoppo and Finley, {Gene G.} and Badylak, {Stephen F.} and Kelly, {Ronan Joseph} and Jobe, {Blair A.}",
year = "2016",
doi = "10.18632/oncotarget.12832",
language = "English (US)",
volume = "7",
pages = "81281--81291",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "49",

}

TY - JOUR

T1 - Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma

AU - Matsui, Daisuke

AU - Zaidi, Ali H.

AU - Martin, Samantha A.

AU - Omstead, Ashten N.

AU - Kosovec, Juliann E.

AU - Huleihel, Luai

AU - Saldin, Lindsey T.

AU - DiCarlo, Christina

AU - Silverman, Jan F.

AU - Hoppo, Toshitaka

AU - Finley, Gene G.

AU - Badylak, Stephen F.

AU - Kelly, Ronan Joseph

AU - Jobe, Blair A.

PY - 2016

Y1 - 2016

N2 - Esophageal adenocarcinoma (EAC) is an aggressive cancer necessitating the development of improved risk stratification tools for personalized care. Previously, microRNAs have been shown to correlate with the progression and prognosis of various cancer types; however, the value in EAC remains largely unexplored. We performed global microRNA profiling on 32 formalin-fixed, paraffin-embedded EAC specimens to identify microRNAs associated with progression. Literature search and pathway analysis further refined output to five significantly deregulated candidate biomarkers. Four of the five microRNAs (miR-652-5p, miR-7-2-3p, miR-3925-3p, and miR-219-3p) were validated by qRT-PCR. Survival outcomes were evaluated in testing set of 26 stage II/III EAC patients to determine the prognostic relevance of the selected microRNAs. In the testing set, miR-652-5p and miR-7-2-3p expressions were significantly associated with progression-free survival (p-value = .00771 and p-value = .00293). The highest area under receiver operating characteristic (ROC) curve was 0.8212 for the combination of miR-652-5p and miR-7-2-3p. Collectively, our findings demonstrated that the miR-652-5p/miR-7-2-3p signature may serve as a promising prognostic marker in patients with locally advanced EAC.

AB - Esophageal adenocarcinoma (EAC) is an aggressive cancer necessitating the development of improved risk stratification tools for personalized care. Previously, microRNAs have been shown to correlate with the progression and prognosis of various cancer types; however, the value in EAC remains largely unexplored. We performed global microRNA profiling on 32 formalin-fixed, paraffin-embedded EAC specimens to identify microRNAs associated with progression. Literature search and pathway analysis further refined output to five significantly deregulated candidate biomarkers. Four of the five microRNAs (miR-652-5p, miR-7-2-3p, miR-3925-3p, and miR-219-3p) were validated by qRT-PCR. Survival outcomes were evaluated in testing set of 26 stage II/III EAC patients to determine the prognostic relevance of the selected microRNAs. In the testing set, miR-652-5p and miR-7-2-3p expressions were significantly associated with progression-free survival (p-value = .00771 and p-value = .00293). The highest area under receiver operating characteristic (ROC) curve was 0.8212 for the combination of miR-652-5p and miR-7-2-3p. Collectively, our findings demonstrated that the miR-652-5p/miR-7-2-3p signature may serve as a promising prognostic marker in patients with locally advanced EAC.

KW - Esophageal adenocarcinoma

KW - miR-652-5p

KW - miR-7-2-3p

KW - miRNA

KW - Prognostic marker

UR - http://www.scopus.com/inward/record.url?scp=85001004321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85001004321&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.12832

DO - 10.18632/oncotarget.12832

M3 - Article

C2 - 27793030

AN - SCOPUS:85001004321

VL - 7

SP - 81281

EP - 81291

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 49

ER -